Ask for position statement on "why, if the cigarette companies do not want to promote smoking among young people, they allow candy cigarette manufacturers to use their brand names". Notes "I do not know that you do 'allow' this. But what is the answer?"
Reminds Soloff "is most articulate in expressing his views on smoking and health". Indicates his three year National Institutes of Health grant in biochemistry is prestigious and "will supplement Dr. Soloff's [Council for Tobacco Research grant in atherosclerosis] so that he will be able to proceed at an accelerated pace".
Updates on three industry-sponsored projects: (1) shared funding of Soloff by Scientific Advisory Board (SAB) and Council for Tobacco Research (CTR) Special Project mechanisms; (2) CTR Special Project support for MacDonald; and (3) Proposed reallocation of funds to support Sterling. Refers to specific previous letters and requests follow-up.
Confirms Soloff's has capable enzyme chemist named Lacko. Adds Hockett "does not believe there is a problem with respect to Soloff reporting on his projects since he generally obtains early publication of his work". Infers Spears may still have questions on matter and notes additional opinions are being sought.
Informs pending conversation with Soloff at the end of the month, the letter requested will be sent.
Confirms Lorillard will participate in Council for Tobaccco Research (CTR) Special Project funding for Ogura's study per Hardy's previous letters.
Quotes Banzhaf's comments from Crossfire transcript regarding future industry product liability suits and requests responses regarding Ogura project per Hardy's earlier letter.
Confirms that Lorillard will participate in Ratcliffe's Council for Tobacco Research (CTR) Special Project funding per previous letter.
Confirms "Lorillard's agreement to participate in the funding of this [Council for Tobacco Research] Special Project relating to Dr. Olkin". Indicates two-year project will be funded at $6,000 per year, references previous correspondence and attaches memorandum "[f]or your additional information and guidance" (attachment missing).
Transmits Olkin's curriculum vitae and his proposal for Council for Tobacco Research (CTR) Special Projects funding for a project entitled "A Study of the Models Used in the Analysis of Certain Medical Data". Indicates how he intends "to examine the theoretical structure of the 'multivariate logistic risk function'", originally used in National Institutes of Health MRFIT study of heart disease in Framingham. Notes Gardner has reviewed and approved the proposal and requests feedback (attachments missing).
Transmits "latest draft of the proposed news release of The Council for Tobacco Research" but advises "to postpone issuance of the release until after the [Weaver case involving American Tobacco] has been completed". Requests individual feedback regarding postponement idea and whether the release needs further editing (attachment missing).
Strategizes about options and issues related to "re-assessment of the 'mission' of CTR [Council for Tobacco Research], with particular reference to whether its function as a grant-making agency is adequate to our needs". Indicates possible replacement of Hartnett with Hockett. Advocates elimination of non-tobacco related funding practices of Scientific Advisory Board (SAB) and suggests contract mechanism may be more appropriate. Argues for policy of "enlightened self-interest" in industry research funding policy and practices.
Indicates Lorillard approves funding Kisen and Battelle Memorial Institute as Council for Tobacco Research [CTR] Special Projects. Reminds "Lorillard has withdrawn from the Tobacco Institute" and assures "[w]e have no plans, of course, for withdrawing" from CTR. Consists of difficult-to-read document.
Transmits confidential memorandum in longhand regarding "Kissen's work", indicating Hockett's endorsement for support from Council for Tobacco Research (CTR). Transmits Battelle Memorial Institute's proposal for "an inhalation study for dogs". Modifies study objectives because "[i]t is not intended, nor expected that there is anything about the test that would permit complete extrapolation of results on dogs to human beings". Requests feedback (attachments missing).
Responds to seven points raised in February 9 letter regarding various Council for Tobacco Research (CTR) and international projects and initiatives, including several animal chronic inhalation studies and "trial relationship" with "David Lawrence, the science writer".
States "Lorillard will participate in the funding of the one year renewal" of Hickey's Council for Tobacco Research (CTR) Special Project at the recommended level. References previous letter "setting forth alternative proposals for [the renewal]".
Itemizes and justifies proposed expenses, including project personnel and their expertise, from Hickey for continuation of his Council for Tobacco Research (CTR) Special Project related to air pollution, smoking, and disease. Describes Hickey's plans for new studies and his recent accomplishments. Recommends approval and indicates CTR's approval. Requests feedback.
Transmits Hickey's article entitled "Maternal smoking, birth weight, infant death, and the self-selection problem" in American Journal of Obstetrics and Gynecology in light of his Council for Tobacco Research (CTR) Special Project support (attachment missing).
Informs per previous conversations and correpondence that issues have been resolved regarding Hickey's Council for Tobacco Research (CTR) Special Project. Indicates "I have advised Dr. Hickey that the project has been approved.
Explains delay in responding to letter regarding Hickey's Council for Tobacco (CTR) Special Project and indicates "[a]ll companies (except Liggett & Myers) have approved the project". Discusses budget allocation issues related to computer time and data analysis. Notes Hickey had been contacted regarding outstanding issues. Indicates additional years of support are contigent after "an evaluation of the progress made under the present project".
Requests response to Spears' comments and questions regarding Hickey's Council for Tobacco Research (CTR) Special Project. Indicates renewal after first year might be possible and that additional year might be required to analyze data collected by project. Enquires "which of the other companies, in addition to RJR [R.J. Reynolds], have agreed to participate in the funding". Includes note in marginalia regarding follow-up call and planned correspondence.
Comments "[t]he October 1st bibliography regarding Dr. Hickey is very interesting" and enquires "[w]hy did you send it?"
Indicates approval of Hickey's Council for Tobacco (CTR) Special Project renewal and that it will be initiated after his final proposal and budget is submitted. Transmits Hickey's publication "on the smoking and pregnancy controversy" in Nature along with Burch's preceding letter, both of which "vigorously criticize the propagandizing of Goldstein relative to the smoking-causality hypothesis" (attachment missing).
Provides background to and advocates bridge funding for continuation of Hickey's Council for Tobacco Research Special Project "critical of the cigarette hypothesis" and relating urban lung cancer mortality to air pollution. Overviews study and plans for publications and presentations and notes applicability of findings in industry litigation.
References previous correspondence and telephone conversation and confirms "willingness to participate" in Sterling, Hickey, and Feinstein projects which "will be handled as CTR [Council for Tobacco Research] special projects".